Castle Biosciences (CSTL) EBT Margin (2018 - 2026)
Castle Biosciences (CSTL) posted EBT Margin of 1.63% for Q2 2026, up 90.52% sequentially from 17.22% in Q1 2026, and down 147.0% YoY from 3.47% in Q2 2025.
Castle Biosciences (CSTL) EBT Margin (2018 - 2026) Analysis & Trends
Castle Biosciences has reported EBT Margin for 9 years, with the latest figure at 1.63% in Q2 2026.
- Quarterly EBT Margin fell 147.0% year-over-year to 1.63% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 5.37% (down 242.0% YoY) and the FY2025 annual result came in at 8.57%, down 1507.0% from the prior year.
- EBT Margin advanced to 1.63% in Q2 2026 per CSTL's latest filing, from 17.22% in the prior quarter.
- Over five years, EBT Margin peaked at 9.65% in Q3 2024 and troughed at 91.2% in Q1 2022.
- A 5-year average of 19.99% and a median of 7.1% in 2023 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2022 and 2024: EBT Margin slumped 7244 bps in 2022, then soared 6603 bps in 2024.
- Over 5 years, EBT Margin stood at 53.63% in 2022, then jumped by 93 bps to 3.84% in 2023, then jumped by 338 bps to 9.14% in 2024, then sank by 134 bps to 3.12% in 2025, then jumped by 48 bps to 1.63% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 1.63%, 17.22%, and 3.12% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 17.21% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -8.93% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 6.89% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 34.29% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 28.17% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 10.36% |
| 10 | Castle Biosciences | 1.04 Bn | 773.13 Mn | 79.85 Mn | -1.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.63% |
| Mar 31, 2026 | -17.22% |
| Dec 31, 2025 | -3.12% |
| Sep 30, 2025 | -0.46% |
| Jun 30, 2025 | -0.17% |
| Mar 31, 2025 | -29.86% |
| Dec 31, 2024 | 9.14% |
| Sep 30, 2024 | 9.65% |
| Jun 30, 2024 | 9.06% |
| Mar 31, 2024 | -3.41% |
| Dec 31, 2023 | -3.84% |
| Sep 30, 2023 | -11.18% |
| Jun 30, 2023 | -37.42% |
| Mar 31, 2023 | -69.44% |
| Dec 31, 2022 | -53.63% |
| Sep 30, 2022 | -54.71% |
| Jun 30, 2022 | -10.35% |
| Mar 31, 2022 | -91.20% |
| Dec 31, 2021 | -60.53% |
| Sep 30, 2021 | -50.23% |